Predictive Markers in Advanced Renal Cell Carcinoma

Seminars in Oncology ◽

10.1053/j.seminoncol.2013.05.001 ◽

2013 ◽

Vol 40 (4) ◽

pp. 459-464 ◽

Author(s):

M. Dror Michaelson ◽

Walter M. Stadler

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Predictive Markers ◽

Advanced Renal Cell Carcinoma

Download Full-text

Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2020.10.003 ◽

2020 ◽

Author(s):

Saskia Lisa Verhaart ◽

Yasmin Abu-Ghanem ◽

Sasja F. Mulder ◽

Sjoukje Oosting ◽

Astrid Van Der Veldt ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

The Netherlands ◽

Cell Carcinoma ◽

Predictive Markers ◽

Advanced Renal Cell Carcinoma ◽

Real World Data ◽

Download Full-text

1305: Zoledronic Acid Reduces Long-Term Risk of Skeletal Complications in Patients with Advanced Renal Cell Carcinoma or Bladder Cancer

The Journal of Urology ◽

10.1016/s0022-5347(18)31519-2 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 429-430 ◽

Author(s):

Peter F. Mulders ◽

Kurt Miller ◽

N. Simon Tchekmedyian

Keyword(s):

Renal Cell Carcinoma ◽

Bladder Cancer ◽

Zoledronic Acid ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Skeletal Complications

Download Full-text

Sunitinib Superior to Interferon-α For Advanced Renal Cell Carcinoma

Internal Medicine News ◽

10.1016/s1097-8690(06)74366-9 ◽

2006 ◽

Vol 39 (20) ◽

pp. 35

Author(s):

FRAN LOWRY

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma ◽

Download Full-text

FDA approves pembrolizumab plus axitinib for advanced renal cell carcinoma

Case Medical Research ◽

10.31525/fda1-ucm636395.htm ◽

2019 ◽

Author(s):

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119981.576105 ◽

2008 ◽

Author(s):

Sharokh Shariat ◽

Jose Karam

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Interferon Alfa ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1147883.604974 ◽

2009 ◽

Author(s):

Keith Flaherty ◽

Stephen Keefe

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Primary Tumor ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13484037.14861147 ◽

2012 ◽

Author(s):

Thomas Powles

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Comparative Effectiveness ◽

Advanced Renal Cell Carcinoma ◽

Download Full-text

Faculty Opinions recommendation of Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737144184.793569177 ◽

2020 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Iii ◽

Advanced Renal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.7577956.9593059 ◽

2011 ◽

Author(s):

Levent Turkeri ◽

Ilker Tinay

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Advanced Renal Cell Carcinoma

Download Full-text

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma

Current Oncology ◽

10.3747/co.v18i0.941 ◽

2011 ◽

Vol 18 (0) ◽

Author(s):

Sebastien J. Hotte ◽

G.A. Bjarnason ◽

D.Y.C. Heng ◽

M.A.S. Jewett ◽

A. Kapoor ◽

...

Keyword(s):

Clinical Trial ◽

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Progression Free Survival ◽

Advanced Renal Cell Carcinoma ◽

Free Survival ◽

Clinical Trial Endpoint ◽

Download Full-text